SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2017 / Cilt: 45 - Sayı: 2

Gebelik sırasında taşiaritmi tedavisi

Management of tachyarrhythmia during pregnancy

Hakan PAYDAK
Emily Ann ENDERLİN
Khaldia TAUFİQ KHALED
Mohammed MADMANİ
Luke OKE
Pages
189–196
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pregnant women with tachyarrhythmia have been successfully treated with little to no impact on the developing fetus as result of increasing experience with antiarrhythmic drugs and progress of new procedural techniques.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Maternal tachyarrhythmia is a common complication during pregnancy due to hormonal changes that enhance pre-existing arrhythmias or induce new arrhythmias in the presence of congenital heart defects in pregnant females.
📊
Key Findings & Data:Presence of tachyarrhythmia during pregnancy poses risk to the mother and fetus, calling for proper treatment with medications.
💡
Conclusion & Impact:Pregnant women with tachyarrhythmia have been successfully treated with little to no impact on the developing fetus as result of increasing experience with antiarrhythmic drugs and progress of new procedural techniques.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Maternal tachyarrhythmia is a common complication during pregnancy due to hormonal changes that enhance pre-existing arrhythmias or induce new arrhythmias in the presence of congenital heart defects in pregnant females. Presence of tachyarrhythmia during pregnancy poses risk to the mother and fetus, calling for proper treatment with medications. Use of antiarrhythmic drugs in cases of maternal tachyarrhythmia must give due consideration of potential teratogenic side effects. Utilization of antiarrhythmic drugs during pregnancy has been well studied; some result in minimal fetal harm or none at all. New techniques, such as cardiac ablation, have also been implemented with minimal or no radiation exposure to the fetus or mother. Pregnant women with tachyarrhythmia have been successfully treated with little to no impact on the developing fetus as result of increasing experience with antiarrhythmic drugs and progress of new procedural techniques.

Özet

- Annede taşiaritmi, hamile kadınlarda önceden var olan aritmileri arttıran veya doğuştan kalp defektleri varlı- ğında yeni aritmileri başlatan hormonal değişikliklere bağlı olarak sık görülen bir komplikasyondur. Gebelik sırasında taşiaritminin varlığı anne ve fetüs için risk oluşturmakta ve ilaçlarla uygun tedaviyi gerektirmektedir. Teratojenik yan et- kilerini de göz önüne alarak maternal taşiaritmide antiarit- mik ilaçların kullanılması düşünülmelidir. Gebelik sırasında antiaritmik ilaçların kullanılması iyice incelenmiş olup bazı- ları minimal fötal hasara yol açacak bazıları hiç zararlı olma- yacaktır. Kardiyak ablasyon gibi yeni teknikler de fetüs veya anneyi minimal (veya hiç) radyasyona maruz bırakmadan uygulanmıştır. Antiaritmik ilaçlarla giderek artan deneyim ve yeni prosedürel tekniklerdeki ilerleme sayesinde gebe ka- dındaki taşiaritmiler başarıyla ve gelişmekte olan fetüse çok az (veya hiç) etkiyle tedavi edilmektedir

🔖

Cite This Article

PAYDAK, H., ENDERLİN, E. A., KHALED, K. T., MADMANİ, M., OKE, L. (2022). Gebelik sırasında taşiaritmi tedavisi. Türk Kardiyoloji Derneği Arşivi, Cilt: 45 - Sayı: 2, 189–196. https://ajindex.com/articles/632294

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ferrero S, Colombo BM, Ragni N. Maternal arrhythmias during pregnancy. Arch Gynecol Obstet 2004;269:244–53
  2. Blomström-Lundqvist C, Scheinman MM. Guidelines for the Management of Patients With Supraventricular Arrhythmias. 2003
  3. Burkart TA, Conti JB. Cardiac arrhythmias during pregnancy. Curr Treat Options Cardiovasc Med 2010;12:457–71
  4. Robins K, Lyons G. Supraventricular tachycardia in pregnancy. Br J Anaesth 2004;92:140–3
  5. Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol 2014;7:961–7
  6. Gowda RM, Khan IA, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol 2003;88:129–33
  7. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97
  8. Mason BA, Ricci-Goodman J, Koos BJ. Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia. Obstet Gynecol 1992;80:478–80
  9. Elkayam U, Goodwin TM. Adenosine therapy for supraventricular tachycardia during pregnancy. Am J Cardiol 1995;75(7):521–3
  10. Joglar JA, Page RL. Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf 1999;20:85–94
  11. Trappe HJ. Acute therapy of maternal and fetal arrhythmias during pregnancy. J Intensive Care Med 2006;21:305–15
  12. Klein V, Repke JT. Supraventricular tachycardia in pregnancy: cardioversion with verapamil. Obstet Gynecol 1984;63(3 Suppl):16–8
  13. Schroeder JS, Harrison DC. Repeated cardioversion during pregnancy. Treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies. Am J Cardiol 1971;27:445–6
  14. Szumowski L, Szufladowicz E, Orczykowski M, Bodalski R, Derejko P, Przybylski A, et al. Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol 2010;21:877–82
  15. Clark JM, Chu S. Catheter Ablation of Supraventricular Tachycardia Without Fluoroscopy During Pregnancy Low Risk ? Indocin Use in Pregnancy Neonatal Outcomes Lean Management System Application in Creation of a Postpartum Hemorrhage Prevention Bundle on Postpartum Units. Am Coll Obstet Gynecol 2014;123:44–5
  16. Forgione FN, Acquati F, Caico SI, Tagliagambe L. Incessant ectopic atrial ta